| Web Site Info |
Endep
Has Said today this will work with USA. Food and Administration Medicine two add extended information of the risk on label Celebrex, following decision declared this morning to require boxed warning the potential cardiovascular risk for the whole pain COX-2 relievers and all NSAIDs, including more Thoughtful not-specific medicine such as, Motrin and naproxen. Boxed warning for all ne-steroidal anti-inflammatory medicine (NSAIDs), including Celebrex, will also contain information for gastrointestinal risk, which be already included elsewhere on their current label..
http://www.morrock.com/endep-p-2289.html
Category: Pharmacies |
|
|
| Thumbshot |
 |
|